Dis-Chem Pharmacies Income Statement

Financials in millions ZAR. Fiscal year is March - February.

Millions ZAR. Fiscal year is Mar - Feb.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 31, 2025	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021
Revenue	40,884	39,172	36,283	32,664	30,407	26,278
Revenue Growth (YoY)	7.62%	7.96%	11.08%	7.42%	15.71%	9.56%
Cost of Revenue	31,726	30,372	28,067	25,076	23,576	20,442
Gross Profit	9,158	8,800	8,217	7,587	6,830	5,836
Selling, General & Admin	1,307	1,307	1,212	984.49	803.97	4,964
Amortization of Goodwill & Intangibles	-	-	-	-	-	55.96
Other Operating Expenses	5,624	5,359	5,201	4,837	4,467	-1,173
Operating Expenses	6,961	6,696	6,437	5,843	5,291	4,495
Operating Income	2,197	2,104	1,779	1,744	1,539	1,341
Interest Expense	-540.33	-521.01	-466.23	-370.45	-324.85	-344.58
Interest & Investment Income	42.07	30.4	26.3	20.21	12.1	16.44
Earnings From Equity Investments	21.79	20.21	45.27	22.78	1.19	3
Other Non Operating Income (Expenses)	-	-	-	-	-0.63	-75.65
EBT Excluding Unusual Items	1,721	1,634	1,385	1,417	1,227	940.49
Other Unusual Items	-	-	-	-	-	0.46
Pretax Income	1,721	1,634	1,385	1,417	1,227	940.94
Income Tax Expense	439.18	414.46	364.09	389.18	337.12	253.29
Earnings From Continuing Operations	1,281	1,219	1,020	1,028	890.1	687.65
Minority Interest in Earnings	-46.23	-39.43	-36.01	-27.32	-36.66	-18.96
Net Income	1,235	1,180	984.48	1,000	853.45	668.69
Net Income to Common	1,235	1,180	984.48	1,000	853.45	668.69
Net Income Growth	16.39%	19.84%	-1.57%	17.20%	27.63%	11.78%
Shares Outstanding (Basic)	857	857	858	860	860	860
Shares Outstanding (Diluted)	858	858	858	860	860	860
Shares Change (YoY)	0.04%	-0.01%	-0.26%	-0.01%	0.08%	0.00%
EPS (Basic)	1.44	1.38	1.15	1.16	0.99	0.78
EPS (Diluted)	1.44	1.38	1.15	1.16	0.99	0.78
EPS Growth	16.33%	19.88%	-1.38%	17.24%	27.55%	11.78%
Free Cash Flow	539.1	-25.46	863.11	230	1,459	762.39
Free Cash Flow Per Share	0.63	-0.03	1.01	0.27	1.70	0.89
Dividend Per Share	0.573	0.548	0.457	0.466	0.397	0.311
Dividend Growth	15.75%	19.89%	-1.79%	17.34%	27.61%	143.11%
Gross Margin	22.40%	22.47%	22.64%	23.23%	22.46%	22.21%
Operating Margin	5.37%	5.37%	4.90%	5.34%	5.06%	5.10%
Profit Margin	3.02%	3.01%	2.71%	3.06%	2.81%	2.54%
Free Cash Flow Margin	1.32%	-0.07%	2.38%	0.70%	4.80%	2.90%
EBITDA	2,654	2,535	2,165	2,079	1,790	1,580
EBITDA Margin	6.49%	6.47%	5.97%	6.36%	5.89%	6.01%
D&A For EBITDA	456.43	431.38	386.14	334.64	250.5	239.03
EBIT	2,197	2,104	1,779	1,744	1,539	1,341
EBIT Margin	5.37%	5.37%	4.90%	5.34%	5.06%	5.10%
Effective Tax Rate	25.52%	25.37%	26.30%	27.47%	27.47%	26.92%
Advertising Expenses	-	632.6	637.81	521.39	394.22	319.03

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.